Estimates Revisions Pharmaron Beijing Co., Ltd.
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.94 CNY | -2.56% |
|
+1.11% | +12.35% |
| Jan. 14 | Pharmaron Beijing to place 58.4 million new H shares at RMB1.00 per share | RE |
| Jan. 14 | Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 300759 Stock
- Consensus Pharmaron Beijing Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
